• +37477445025
  • info@adelvas.com
  • 0025, 2 st aygestan, 17, Yerevan , Armenia

Areas of Operation of Our Company within the Framework of the Eurasian Economic Union

We are a dynamically growing pharmaceutical company specializing in the Eurasian Economic Union (EAEU) market. Our objective is to highlight key operational domains and expertise offered to partners.
The EAEU market demands profound knowledge due to its unique regulatory landscape, including harmonized legislation, implementation of unified Good Practices (GxP), and product registration procedures. We possess the requisite resources and competencies to ensure successful operations and end-to-end product commercialization management across the EAEU.

Sales and Distribution in the EAEU Market

We deliver efficient sales and distribution services, ensuring timely patient access to pharmaceuticals across the EAEU while adhering to quality standards and regulatory requirements.

Key Competencies:

  • High-Performance Sales Team: Our qualified professionals possess extensive experience in engaging healthcare providers (HCPs) and pharmacies, coupled with deep knowledge of EAEU regulatory frameworks and local market dynamics. We employ strategic recruitment and training processes, including mandatory compliance with Good Distribution Practice (GDP), and utilize advanced data-driven approaches for personalized engagement.

  • Strategic Stakeholder Engagement: We establish long-term, ethical relationships with HCPs and pharmacies by providing relevant information and educational resources.

  • Advanced Customer Relationship Management (CRM): Cutting-edge CRM systems centralize contact management, track interactions, segment audiences, and ensure regulatory compliance.

  • EAEU GDP Compliance: Our distribution operations strictly align with EAEU GDP standards. We have implemented a Quality Management System (QMS), appointed a Responsible Person, and established protocols to maintain product integrity.

Commercial Product Launch

We offer extensive expertise and capabilities for compliant and effective commercial product launches across the EAEU.

Our Capabilities:

  • EAEU Registration Expertise: Proficient in EAEU registration procedures, including Mutual Recognition (MRP) and Decentralized (DCP) pathways. We prepare dossiers in electronic Common Technical Document (eCTD) format, specialize in aligning national registrations with EAEU requirements ahead of the December 31, 2025 deadline, and provide strategic guidance on Reference Member State (RMS) selection.

  • Pharmacovigilance (GVP) and Clinical Trial Support (GCP): We maintain pharmacovigilance systems compliant with EAEU Good Pharmacovigilance Practice (GVP), including a Qualified Person for Pharmacovigilance (QPPV) and Pharmacovigilance System Master File (PSMF). We support clinical trials in line with EAEU Good Clinical Practice (GCP).

  • GMP Inspection Management and Import Licenses: We coordinate GMP inspections for international manufacturing sites, prepare Site Master Files (SMF), liaise with inspectors, and develop Corrective and Preventive Action (CAPA) plans. We also facilitate import license acquisition.

Strategic Marketing and Brand Development

Our marketing strategy focuses on brand value creation, targeted engagement with healthcare stakeholders, and demand generation within the EAEU.

Marketing Activities:

  • Brand Building: We cultivate a consistent, recognizable brand through identity alignment, ethical communication, and compliance.

  • Key Opinion Leader (KOL) and HCP Engagement: We systematically identify and collaborate with leading specialists, leveraging their expertise throughout the product lifecycle to foster long-term relationships grounded in scientific exchange and trust.

  • Event Management: We organize promotional and educational events (seminars, webinars, conferences) for HCPs, prioritizing knowledge-sharing and high-value content.

  • Digital Marketing: We execute EAEU-compliant digital strategies via online platforms, content marketing, email campaigns, and virtual events.

Comprehensive Market Access Strategy

Market access is central to our operations. We enable patient availability of innovative therapies within EAEU healthcare systems.

Market Access Competencies:

  • Pricing and Reimbursement: Expertise in price registration and inclusion in national lists, such as the Essential and Vital Drugs List (EDL). We prepare for Health Technology Assessments (HTA) and develop pricing/reimbursement strategies emphasizing clinical and economic value.

  • Collaboration with Associations and KOLs: Partner with professional associations and specialists to achieve market access goals.

  • Clinical Guideline Integration: Support product inclusion in clinical guidelines through robust data and procedural insights.

  • Sales Channel Presence: Secure placements in leading pharmacy chains and online platforms, ensuring compliance with e-commerce regulations.

Pharmaceutical Logistics and Supply Chain Management

Our logistics expertise ensures secure, compliant, and timely product delivery across the EAEU.

Logistics Capabilities:

  • EAEU Distribution Network: A pan-EEU network enables seamless cross-border distribution and flexible batch processing.

  • GDP and Cold Chain Compliance: Adherence to EAEU GDP standards during transportation, including temperature monitoring, validated packaging, and cold chain management. GDP-trained personnel and QMS ensure full compliance.

  • Customs Clearance: Accelerated customs processing with expertise in EAEU documentation.

  • Last-Mile Delivery: Reliable end-user delivery solutions, including small-volume shipments and temperature-controlled logistics.

Expert Operational Profile Assessment

Competency and Competitive Analysis:
Our services cover critical commercialization stages. Expertise in EAEU-specific regulations (GDP, GVP, registration, EDL) and integrated solutions position us as a comprehensive partner.

Strengths and Improvement Opportunities:

  • Strengths:

    • End-to-end service portfolio.

    • Deep EAEU regulatory and market access expertise.

    • Relationship-driven approach with skilled personnel.

    • Full compliance with EAEU standards.

  • Improvement Areas:

    • Digital Transformation: Enhance digital marketing and CRM.

    • Data Analytics: Refine data-driven personalization.

    • Specialized Logistics: Highlight cold chain technologies.

    • Sustainability: Incorporate ESG initiatives.

Strategic Growth Opportunities (Excluding R&D and Manufacturing)

We identify synergistic service expansions:

  • Licensing and Partnership Facilitation.

  • Contract Manufacturing Organization (CMO/CDMO) Management.

  • Patient Support Programs (PSPs).

  • Medical Affairs Services: Medical education and information support.

  • Advanced Regulatory Consulting: Complex EAEU regulatory strategy.

  • Health Economics and Outcomes Research (HEOR): Local value evidence generation.

These avenues leverage our infrastructure and expertise to deliver a full spectrum of EAEU commercialization services.